The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Italian firm Pavesi Gitti Verzoni advised Rottapharm on its sale, led by partner Carlo Pavesi.
Background to this deal:
Reed Smith has a close relationship with Meda, having first advised the Swedish company on its $392m acquisition of US giant Valeant’s pharmaceutical business in Europe in 2008. Sullivan & Cromwell took the key role for Valeant on that transaction.
The deal is the latest in a wave of global pharmaceuticals and healthcare consolidation transactions to shake the sector this year. Others include Shire Pharmaeuticals’ £32bn acquisition by AbbVie (10 July 2014), Zimmer’s £8bn acquisition of Biomet (27 April 2014), Novaris’ £11.9bn worth of transactions with GlaxoSmithKline (22 April 2014), and Pfizer’s £62bn failed bid for AstraZeneca (28 April 2014).